Pr Thomas Decaens
- Spécialité
- Oncologue médical, expert foie
- Titre
- Chef de service
- Hôpital
- Centre Hospitalier Université Grenoble Alpes (Grenoble)
- Derniers articles
-
- Real-World Outcomes of Atezolizumab-Bevacizumab in Hepatocellular Carcinoma: The Prospective French CHIEF Cohort. (1 oct. 2025)
- Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapy. (1 sept. 2025)
- A multicentric national phase II trial assessing TIslelizumab in monotherapy for patients with Hepatocellular Carcinoma Child-Pugh B and ALBI grade 1 or 2 liver function score: The UCGI 41 HESTIA TRIAL DESIGN AND PRELIMINARY SAFETY Data. (1 août 2025)
- Alcohol Consumption After Listing for Liver Transplantation Is Associated With Increased Risk of Alcohol Consumption After Transplantation. (26 juin 2025)
- Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial. (24 mai 2025)